Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimers disease. The Company’s products include Simufilam and SavaDx. Its lead... Read more
MarketWatch
SeekingAlpha
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.